A detailed history of Schonfeld Strategic Advisors LLC transactions in Geron Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 782,372 shares of GERN stock, worth $2.61 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
782,372
Previous 155,432 403.35%
Holding current value
$2.61 Million
Previous $659,000 438.85%
% of portfolio
0.03%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $2.61 Million - $3.13 Million
626,940 Added 403.35%
782,372 $3.55 Million
Q2 2024

Aug 14, 2024

SELL
$3.1 - $5.09 $427,688 - $702,236
-137,964 Reduced 47.02%
155,432 $659,000
Q1 2024

May 15, 2024

BUY
$1.75 - $3.44 $513,443 - $1.01 Million
293,396 New
293,396 $968,000
Q4 2022

Feb 14, 2023

BUY
$2.03 - $2.42 $18,146 - $21,632
8,939 Added 14.41%
70,964 $171,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $103,581 - $182,353
62,025 New
62,025 $145,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.26B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.